Premier Research

Leap Therapeutics, based in Cambridge, MA, is dedicated to developing targeted and immuno-oncology therapeutics, with a focus on innovative treatments for various cancer types, including gastric, colorectal, and gynecologic cancers. Their lead candidate, DKN-01, is a humanized monoclonal antibody that targets the Dickkopf-1 (DKK1) protein and is currently in clinical development for patients with DKK1-expressing tumors. In addition to DKN-01, Leap Therapeutics is advancing FL-301, which targets Claudin18.2 for gastric and pancreatic cancers, and FL-501, a preclinical candidate that targets the growth and differentiation factor 15 (GDF-15) protein. The company is committed to understanding tumor expression and discovering new therapeutic targets and combinations to improve cancer treatment outcomes. Generated from the website

Founded in 1980, Amgen is one of the leading companies in the biotechnology industry. The company discovers, develops, manufactures and delivers human therapeutic products. It provides therapeutic services to treat a range of illnesses that includes cancers, kidney diseases and rheumatoid arthritis. Amgen also offers services to treat autoimmune diseases, such as psoriatic arthritis and ankylosing spondylitis. The company works with a team of more than 17,500 staff members. It is affiliated with Biotechnology industry Organization, Healthcare Leadership Council and Pharmaceutical Research manufacturers of America. Amgen conducts research programs related to inflammation, metabolism disorders, osteoporosis, neuroscience, oncology and hematology. Headquartered in Thousand Oaks, Calif., it maintains a location in West Greenwich, R.I.

CardioFocus Inc, based in Marlborough, MA, specializes in providing electrophysiologists with advanced technologies for the treatment of atrial fibrillation. Their innovative solutions, including the HeartLight X3 and Centauri System, leverage state-of-the-art laser technology and customized waveform designs to enhance precision and efficiency in cardiac procedures. Committed to ongoing research and development, CardioFocus enables physicians to streamline ablation procedures while maintaining high standards of patient care. Their products focus on delivering effective outcomes through features like real-time tissue visualization and integration with leading mapping systems, marking a significant advancement in the management of complex cardiac arrhythmia. Generated from the website